• Login

    • Forgot your password ?
    • Forgot your username ?
  • Sign Up
    (*)
    (*)
    (*)
    (*)
    (*)
    (*)
    (*)

    Fields marked with an asterisk (*) are required.

ESIM ESIM
  • Home
  • About Us
    • Leadership
    • Mission, Vision and Values
  • News and Events
  • CPD
  • Opinions
    • Our Story
  • Resources & Opportunities
    • Download
    • Residents' Hub
    • From the Web
  • Contact

FDA approves pangenotypic drug for Hepatits C

  • Print
  • Email

The FDA has approved Epclusa, a combination of SofosbuvirĀ  and VelpatasvirĀ  as a treatment of all genotypes of Hepatitis C.

No plugin selected!

ESIM

Copyright © 2021 ESIM. All Rights Reserved. Designed by Firma.

Get our Newsletter

Free email design tips every month. See past issues.